Author

P. Zolkind

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Research Focus:differential expression· 2 Organism:human· 2 Research Focus:cell signaling & trafficking· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Research Focus:host-pathogen & immune response· 1 Assay:multiome· 1

Frequent Co-Authors

A. Mazul· 1 shared B. Holmes· 1 shared B. M. Wahle· 1 shared D. Adkins· 1 shared D. Goldfarb· 1 shared D. N. Hayes· 1 shared E. Wilkerson· 1 shared J. P. Zevallos· 1 shared

Activity by Year

2021-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Mazul

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Targeted proteomic quantitation of NRF2 signaling and predictive biomarkers in HNSCC

N. Wamsley, E. Wilkerson, L. Guan, K. LaPak, T. Schrank, B. Holmes, R. Sprung, P. E. Gilmore, S. Gerndt, R. Jackson, R. Paniello, P. Pipkorn, S. V. Puram, J. Rich, R. R. Townsend, , M. B. Major

This paper develops a targeted proteomics assay to quantify NRF2 pathway components and clinical biomarkers in HNSCC, identifying correlations between NRF2 activity, HPV infection, and immune markers.

bioRxiv · Mar 13, 2023Cancer Biology

Comparative Multiomic Analysis Reveals Low T Cell Infiltration as the Primary Feature of Tobacco Use in HPV(+) Oropharyngeal Cancer

B. M. Wahle, P. Zolkind, R. Ramirez, Z. L. Skidmore, A. Mazul, D. N. Hayes, V. C. Sandulache, W. L. Thorstad, D. Adkins, O. L. Griffith, M. Griffith, J. P. Zevallos

This study identifies low T cell infiltration as a key feature of tobacco use in HPV-positive oropharyngeal cancer, linked to worse outcomes.

bioRxiv · Mar 23, 2021 · PreprintCancer Biology